Reversing multidrug resistance by tyrosine kinase inhibitors
Authors:
Open Access
- 5 March 2012
- journal article
- review article
- Published by Editorial Office of Chinese Journal of Cancer in Chinese Journal of Cancer
- Vol. 31 (3) , 126-133
Abstract
Recently, a large number of tyrosine kinase inhibitors(TKIs) have been developed as anticancer agents. These TKIs can specifically and selectively inhibit tumor cell growth and metastasis by targeting various tyrosine kinases and thereby interfering with cellular signaling pathways. The therapeutic potential of TKIs has been hindered by multidrug resistance(MDR), which is commonly caused by overexpression of ATP-binding cassette(ABC) membrane transporters. Interestingly, some TKIs have also been found to reverse MDR by directly inhibiting the function of ABC transporters and enhancing the efficacy of conventional chemotherapeutic drugs. In this review, we discuss ABC transporter-mediated MDR to TKIs and MDR reversal by TKIs.Keywords
This publication has 67 references indexed in Scilit:
- Dasatinib: An Anti-Tumour Agent via Src InhibitionCurrent Drug Targets, 2011
- Nilotinib: A Novel, Selective Tyrosine Kinase InhibitorSeminars in Oncology, 2011
- Tyrosine kinase inhibitors as modulators of ATP binding cassette multidrug transporters: substrates, chemosensitizers or inducers of acquired multidrug resistance?Expert Opinion on Drug Metabolism & Toxicology, 2011
- PazopanibDrugs, 2011
- Effect of BIBF 1120 on reversal of ABCB1-mediated multidrug resistanceCellular Oncology, 2011
- Multidrug Resistance Protein 2 Implicates Anticancer Drug-Resistance to SorafenibBiological and Pharmaceutical Bulletin, 2011
- P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase InhibitorDrug Metabolism Letters, 2010
- Sorafenib modulates the gene expression of multi-drug resistance mediating ATP-binding cassette proteins in experimental hepatocellular carcinoma.2010
- Apatinib (YN968D1) Reverses Multidrug Resistance by Inhibiting the Efflux Function of Multiple ATP-Binding Cassette TransportersCancer Research, 2010
- Interaction of Tyrosine Kinase Inhibitors with the MDR-Related ABC Transporter ProteinsCurrent Drug Metabolism, 2010